Imunon (IMNN) Accounts Payables (2010 - 2026)
Imunon's (IMNN) quarterly Accounts Payables came in at $964590.0 in Q1 2026, down 48.1% YoY from $1.9 million in Q1 2025, and down 30.75% on a QoQ basis from $1.4 million in Q4 2025.
Imunon (IMNN) Accounts Payables (2010 - 2026) Analysis & Trends
Imunon (IMNN) has 17 years of Accounts Payables data on file, last reported at $964590.0 in Q1 2026.
- Quarterly Accounts Payables fell 48.1% year-over-year to $964590.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $964590.0 (down 48.1% YoY) and the FY2025 annual result came in at $1.4 million, up 7.14% from the prior year.
- Accounts Payables retreated to $964590.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $4.0 million in Q1 2023 to a low of $964590.0 in Q1 2026.
- A 5-year average of $2.3 million and a median of $2.2 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 65.02% — and 2024, when it plunged 63.02%.
- Tracing IMNN's Accounts Payables over 5 years: stood at $3.6 million in 2022, then slipped by 1.99% to $3.5 million in 2023, then sank by 63.02% to $1.3 million in 2024, then advanced by 7.14% to $1.4 million in 2025, then sank by 30.75% to $964590.0 in 2026.
- The last three Accounts Payables figures came in at $964590.0 (Q1 2026), $1.4 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Imunon | 8.39 Mn | 8.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 964,590.00 |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 2.61 Mn |
| Mar 31, 2023 | 3.97 Mn |
| Dec 31, 2022 | 3.59 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 2.39 Mn |
| Mar 31, 2022 | 3.47 Mn |
| Dec 31, 2021 | 2.55 Mn |
| Sep 30, 2021 | 2.62 Mn |
| Jun 30, 2021 | 2.11 Mn |
| Mar 31, 2021 | 2.10 Mn |